InsidersTradesSigma
Explore the complete record of transactions filed by EMPFIELD JAMES R., Vice-Président Exécutif, Découverte de Médicaments. Insider active across 1 companies, notably Xenon Pharmaceuticals Inc.. In total, 1 filings have been logged. The latest transaction was filed on 4 March 2022 (Levée d'options). Regulator: SEC (Form 4). All data is free.
1 of 1 declaration
EMPFIELD JAMES R. serves as Executive Vice President of Drug Discovery at Xenon Pharmaceuticals Inc. He leads research and development efforts to discover new treatments. His expertise contributes to innovation and advancement of the company's pharmaceutical projects.